Published in

Springer (part of Springer Nature), Cancer Immunology, Immunotherapy, 2(52), p. 89-96, 2003

DOI: 10.1007/s00262-002-0362-7

Links

Tools

Export citation

Search in Google Scholar

The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes.

Journal article published in 2003 by Wolfgang M. Wagner, Qin Ouyang, Graham Pawelec ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO